mhurhangee/ep-ind-claims huggingface dataset:
Central gateway controller for managing data that are transmitted via an on-board electrical system, comprising: at least one central communication server, ZKS, comprising: ― at least one central information store, ZIA, for the central storage of data that are transmitted via the on-board electrical system, ― at least one communication module (130, 132, 134, 136) for transmitting data between the ZIA and at least one bus system (160, 162, 164, 166) belonging to the on-board electrical system; characterized in that the gateway controller is configured to store the data transmitted via the communication module (130, 132, 134, 136) and converted into a uniform data format in the ZIA, wherein the data stored in the uniform data format in the ZIA and useful data present therein are able to be accessed actively and/or the useful data present in the data are able to be processed. at least one central communication server, ZKS, comprising: ― at least one central information store, ZIA, for the central storage of data that are transmitted via the on-board electrical system, ― at least one communication module (130, 132, 134, 136) for transmitting data between the ZIA and at least one bus system (160, 162, 164, 166) belonging to the on-board electrical system; ― at least one central information store, ZIA, for the central storage of data that are transmitted via the on-board electrical system, ― at least one communication module (130, 132, 134, 136) for transmitting data between the ZIA and at least one bus system (160, 162, 164, 166) belonging to the on-board electrical system; characterized in that the gateway controller is configured to store the data transmitted via the communication module (130, 132, 134, 136) and converted into a uniform data format in the ZIA, wherein the data stored in the uniform data format in the ZIA and useful data present therein are able to be accessed actively and/or the useful data present in the data are able to be processed.
Membrane comprising a block copolymer comprising polyarylene ether blocks and polyalkylene oxide blocks, wherein said polyalkylene oxide blocks comprise at least one polyethylene oxide segment and at least one segment of at least one polyalkylene oxide that is different from polyethylene oxide, wherein said polyarylene ether blocks correspond to formula IV wherein D represents a chemical bond or O, Ar = 1,4-phenylene, t = 1, q = 0, T = SO 2 and Y = SO2 and wherein said polyalkylene oxide blocks comprise ethyleneoxide segments at the terminal positions of said alkylene oxide blocks.
A method of densifying porous substrates using chemical vapour infiltration ("CVI") in a CVI furnace, wherein the CVI furnace comprises a precursor gas preheating zone and a reaction chamber in which the porous substrates are densified, the CVI furnace comprising a bottom wall separating the precursor gas preheating zone and the reaction chamber, the bottom wall having a plurality of openings formed therethrough corresponding to a plurality of locations at which stacks of the porous substrates are positioned, the method of densifying comprising: arranging at least a first plurality of stacks of porous substrates in the reaction chamber, wherein stacks of porous substrates located at a periphery of the reaction chamber are undensified porous substrates, partially densified porous substrates, or a combination of undensified and partially densified porous substrates, and one or more stacks of partially densified substrates are located at a central location among the first plurality of stacks of porous substrates, and densifying the at least first plurality of stacks of porous substrates using a chemical vapour infiltration process. arranging at least a first plurality of stacks of porous substrates in the reaction chamber, wherein stacks of porous substrates located at a periphery of the reaction chamber are undensified porous substrates, partially densified porous substrates, or a combination of undensified and partially densified porous substrates, and one or more stacks of partially densified substrates are located at a central location among the first plurality of stacks of porous substrates, and densifying the at least first plurality of stacks of porous substrates using a chemical vapour infiltration process.
A method for calibrating an offset voltage at one or more inputs to an amplifier, comprising: applying a common voltage to the one or more inputs to the amplifier, wherein the amplifier is used to amplify capacitively coupled communication signals; and iteratively: measuring an output of the amplifier, determining an offset voltage based on the measured output of the amplifier; and applying charge to the one or more inputs to the amplifier until the determined offset voltage is less than a pre-determined value, wherein applying the charge involves applying a sequence of one or more charge pulses, wherein a given charge pulse in the sequence of charge pulses contains a pre-defined charge. applying a common voltage to the one or more inputs to the amplifier, wherein the amplifier is used to amplify capacitively coupled communication signals; and iteratively: measuring an output of the amplifier, determining an offset voltage based on the measured output of the amplifier; and applying charge to the one or more inputs to the amplifier until the determined offset voltage is less than a pre-determined value, wherein applying the charge involves applying a sequence of one or more charge pulses, wherein a given charge pulse in the sequence of charge pulses contains a pre-defined charge. measuring an output of the amplifier, determining an offset voltage based on the measured output of the amplifier; and applying charge to the one or more inputs to the amplifier until the determined offset voltage is less than a pre-determined value, wherein applying the charge involves applying a sequence of one or more charge pulses, wherein a given charge pulse in the sequence of charge pulses contains a pre-defined charge.
Method for determining the filling level of a filling material located in a container by means of a filling level measuring device, comprising the following method steps: - Emitting a transmission signal (S HF) in the direction of the product, - Receiving a received signal (E HF) that depends on the measuring distance (d), - Create an evaluation curve (A(d)) using at least the received signal, HF - Smoothing of the evaluation curve (A(d)) using at least one filter method, - Determination of the fill level using the smoothed evaluation curve (A(d)), whereby the evaluation curve (A(d)) is smoothed to varying degrees depending on the measurement distance (d), wherein low-pass filtering, in particular moving average filtering and/or in particular moving maximum value filtering is used as the filter method for smoothing the evaluation curve (A(d)), whereby the measuring distance (d) is divided into a close range, a medium range and a long range, characterized in that the smoothing is set lower in the close range and in the end range compared to the middle sub-range. - Emitting a transmission signal (S HF) in the direction of the product, - Receiving a received signal (E HF) that depends on the measuring distance (d), - Create an evaluation curve (A(d)) using at least the received signal, HF - Smoothing of the evaluation curve (A(d)) using at least one filter method, - Determination of the fill level using the smoothed evaluation curve (A(d)), whereby the evaluation curve (A(d)) is smoothed to varying degrees depending on the measurement distance (d), wherein low-pass filtering, in particular moving average filtering and/or in particular moving maximum value filtering is used as the filter method for smoothing the evaluation curve (A(d)), whereby the measuring distance (d) is divided into a close range, a medium range and a long range, characterized in that the smoothing is set lower in the close range and in the end range compared to the middle sub-range.
A pharmaceutical composition for use in preventing and/or treating cutaneous photodamage and/or skin inflammation, said pharmaceutical composition being characterized by a water-soluble extract from a plant of Solanum genus, said water-soluble extract comprising solamargine and solasonine, and said water-soluble extract being obtainable by the following steps: (a) subjecting a plant material of a plant of Solanum genus to an extraction treatment using an acidic aqueous solution with a pH value of 3∼5, such that an aqueous solution is obtained; (b) adjusting the pH value of the aqueous solution obtained in step (a) to pH 8∼10 with a base, such that a precipitate is formed; (c) washing the precipitate formed in step (b) with water, followed by drying, such that a dried product is obtained; (d) admixing the dried product obtained in step (c) with chloroform, followed by addition of a suitable amount of a 100% alcohol, such that a chloroform-alcohol mixture is formed; (e) mixing the chloroform-alcohol formed in step (d) with a water/alcohol solution having a predetermined water/alcohol ratio, such that a mixture containing a chloroform-based layer and a non-chloroform-based layer is obtained; (f) removing the chloroform-based layer from the mixture obtained in step (e), followed by addition of a suitable amount of water; and (g) obtaining a supernatant from the resultant mixture of step (f), followed by drying the supernatant, wherein the resultant dried product is able to be directly dissolved in water to form a yellowish clear and transparent aqueous solution. (a) subjecting a plant material of a plant of Solanum genus to an extraction treatment using an acidic aqueous solution with a pH value of 3∼5, such that an aqueous solution is obtained; (b) adjusting the pH value of the aqueous solution obtained in step (a) to pH 8∼10 with a base, such that a precipitate is formed; (c) washing the precipitate formed in step (b) with water, followed by drying, such that a dried product is obtained; (d) admixing the dried product obtained in step (c) with chloroform, followed by addition of a suitable amount of a 100% alcohol, such that a chloroform-alcohol mixture is formed; (e) mixing the chloroform-alcohol formed in step (d) with a water/alcohol solution having a predetermined water/alcohol ratio, such that a mixture containing a chloroform-based layer and a non-chloroform-based layer is obtained; (f) removing the chloroform-based layer from the mixture obtained in step (e), followed by addition of a suitable amount of water; and (g) obtaining a supernatant from the resultant mixture of step (f), followed by drying the supernatant, wherein the resultant dried product is able to be directly dissolved in water to form a yellowish clear and transparent aqueous solution.
Method for selective initiation of expression of a protein-encoding sequence, which is independent of the carbon source used for growth of a filamentous fungus, in a filamentous fungus cell comprising the steps a) Introducing a promotor of SEQ ID NO:3 into the filamentous fungus cell; b) Contacting the filamentous fungus cell containing the promotor with a growth medium; c) Adding at least one organic acid to the growth medium to initiate transcription of the protein-encoding sequence. a) Introducing a promotor of SEQ ID NO:3 into the filamentous fungus cell; b) Contacting the filamentous fungus cell containing the promotor with a growth medium; c) Adding at least one organic acid to the growth medium to initiate transcription of the protein-encoding sequence.
A vaporizer comprising: at least one capsule including: a material containing at least one active ingredient; a first covering layer (30, 60, 66) and a second covering layer (30, 60, 66) that are configured to cover the material, the first covering layer (30, 60, 66) and the second covering layer (30, 60, 66) opposing each other and being configured to direct an airflow into the first covering layer (30, 60, 66), through at least a portion of the material, and out of the second covering layer (30, 60, 66) during an operational use of the at least one capsule; an internal heating element within the at least one capsule; and control circuitry configured to perform a classification of a type of the at least one capsule and to implement a heating of the at least one capsule via the internal heating element based on the classification to at least partially vaporize the at least one active ingredient of the material. at least one capsule including: a material containing at least one active ingredient; a first covering layer (30, 60, 66) and a second covering layer (30, 60, 66) that are configured to cover the material, the first covering layer (30, 60, 66) and the second covering layer (30, 60, 66) opposing each other and being configured to direct an airflow into the first covering layer (30, 60, 66), through at least a portion of the material, and out of the second covering layer (30, 60, 66) during an operational use of the at least one capsule; an internal heating element within the at least one capsule; and a material containing at least one active ingredient; a first covering layer (30, 60, 66) and a second covering layer (30, 60, 66) that are configured to cover the material, the first covering layer (30, 60, 66) and the second covering layer (30, 60, 66) opposing each other and being configured to direct an airflow into the first covering layer (30, 60, 66), through at least a portion of the material, and out of the second covering layer (30, 60, 66) during an operational use of the at least one capsule; an internal heating element within the at least one capsule; and control circuitry configured to perform a classification of a type of the at least one capsule and to implement a heating of the at least one capsule via the internal heating element based on the classification to at least partially vaporize the at least one active ingredient of the material.
A flexible and pushable catheter tip having a proximal end and a distal end, comprising: a spring-like element extending toward a distal-most edge of the catheter tip; and a longitudinally flexible tube having a luminal inside and a vessel wall outside, said spring-like element extends along said longitudinally flexible tube, said spring-like element located at a position inside said longitudinally flexible tube, a spacer portion located proximally of said spring-like element wherein said spacer portion is an extension of said longitudinally flexible tube; wherein said spring-like element provides longitudinal flexibility and pushability to said catheter tip, and wherein said spring-like element is a single coiled wire. a spring-like element extending toward a distal-most edge of the catheter tip; and a longitudinally flexible tube having a luminal inside and a vessel wall outside, said spring-like element extends along said longitudinally flexible tube, said spring-like element located at a position inside said longitudinally flexible tube, a spacer portion located proximally of said spring-like element wherein said spacer portion is an extension of said longitudinally flexible tube; wherein said spring-like element provides longitudinal flexibility and pushability to said catheter tip, and wherein said spring-like element is a single coiled wire.
A process for producing a 3D tissue culture model, the process comprising: (a) printing a drop of bio-ink to a substrate; (b) printing a drop of activator to the drop of bio-ink to form a hydrogel droplet; (c) repeating steps (a) and (b) in any order to form a hydrogel mold adapted to receive a drop containing cells; (d) printing a drop containing cells having a cell concentration of 10 7 cells/ml or greater to the hydrogel mold; and (e) repeating steps (a) and (b) in any order to form a 3D tissue culture model comprising the cells encapsulated in the hydrogel mold; wherein the printing is carried out using a printer having a drop-on-demand droplet dispensing system. (a) printing a drop of bio-ink to a substrate; (b) printing a drop of activator to the drop of bio-ink to form a hydrogel droplet; (c) repeating steps (a) and (b) in any order to form a hydrogel mold adapted to receive a drop containing cells; (d) printing a drop containing cells having a cell concentration of 10 7 cells/ml or greater to the hydrogel mold; and (e) repeating steps (a) and (b) in any order to form a 3D tissue culture model comprising the cells encapsulated in the hydrogel mold;
An actinic ray-curable-type inkjet ink set for three-dimensional printing, comprising: a white ink composition W; a color ink composition C; and an ink composition for a support material, wherein the white ink composition W contains a white pigment and a polymerizable compound, in which the content of the white pigment is 0.5% by mass to 10% by mass with respect to the total mass of the white ink composition W, the color ink composition C contains a colorant, an acrylate monomer AC which forms a homopolymer having a glass transition temperature of 25 °C to 120°C, and an acrylate monomer BC which forms a homopolymer having a glass transition temperature of -60°C or higher and lower than 25°C, in which, with respect to the total mass of the color ink composition C, the content of the acrylate monomer AC is 5% by mass or more and less than 50% by mass and the content of the acrylate monomer BC is 20% by mass or more and less than 80% by mass, and the ink composition for a support material contains a monofunctional acrylate compound, a polymerization initiator, and a water-soluble non-curing component, in which, with respect to the total mass of the ink composition for a support material, the content of a polyfunctional acrylate compound is 5% by mass or less, and a colorant is not substantially contained in the ink composition for a support material. a white ink composition W; a color ink composition C; and an ink composition for a support material, wherein the white ink composition W contains a white pigment and a polymerizable compound, in which the content of the white pigment is 0.5% by mass to 10% by mass with respect to the total mass of the white ink composition W, the color ink composition C contains a colorant, an acrylate monomer AC which forms a homopolymer having a glass transition temperature of 25 °C to 120°C, and an acrylate monomer BC which forms a homopolymer having a glass transition temperature of -60°C or higher and lower than 25°C, in which, with respect to the total mass of the color ink composition C, the content of the acrylate monomer AC is 5% by mass or more and less than 50% by mass and the content of the acrylate monomer BC is 20% by mass or more and less than 80% by mass, and the ink composition for a support material contains a monofunctional acrylate compound, a polymerization initiator, and a water-soluble non-curing component, in which, with respect to the total mass of the ink composition for a support material, the content of a polyfunctional acrylate compound is 5% by mass or less, and a colorant is not substantially contained in the ink composition for a support material.
Method for analysing an additive manufacturing process, which involves detecting measurement values concerning at least one process emission during the manufacture of a workpiece, wherein average values and standard deviations of the measurement values of predefined volume elements of the workpiece are calculated, wherein measurement values concerning at least one measurement variable representing process luminous emission are detected as measurement values concerning the at least one process emission during the manufacture of the workpiece, and wherein a distribution of the calculated standard deviations of a plurality of predefined volume elements is checked as a measure of the process quality, characterized in that from the calculated average values and standard deviations, variation coefficients are formed, a moving average value of the variation coefficients over a window of predefined volume elements is formed and a check is carried out as to whether the moving average value lies within a predefined interval, and if the predefined interval is exceeded, it is deduced that a fault was present, and the interval is predefined as a function of the moving average values over the predefined window.
An ultrasonic mist inhaler, comprising: a mouthpiece for inhaling mist, a liquid reservoir structure comprising a liquid chamber adapted to receive liquid to be atomized, a sonication chamber in fluid communication with the liquid chamber, the sonication chamber comprising means of ultrasonic vibrations, a capillary element arranged between the liquid chamber and the sonication chamber, wherein at least part of the liquid reservoir structure and the mouthpiece form the sonication chamber, wherein the capillary element comprises a central portion and a peripheral portion, the peripheral portion having an L-shape cross section extending down to the liquid chamber, the central portion having a U-shape cross section extending to the sonication chamber, the U-shape cross section having an inner portion (7a1) and an outer portion (7a2), the inner portion of the U-shape cross section (7a1) being in surface contact with the means of ultrasonic vibrations and the outer portion of the U-shape cross section (7a2) being not in surface contact with the means of ultrasonic vibrations. a mouthpiece for inhaling mist, a liquid reservoir structure comprising a liquid chamber adapted to receive liquid to be atomized, a sonication chamber in fluid communication with the liquid chamber, the sonication chamber comprising means of ultrasonic vibrations, a capillary element arranged between the liquid chamber and the sonication chamber, wherein at least part of the liquid reservoir structure and the mouthpiece form the sonication chamber, wherein the capillary element comprises a central portion and a peripheral portion, the peripheral portion having an L-shape cross section extending down to the liquid chamber, the central portion having a U-shape cross section extending to the sonication chamber, the U-shape cross section having an inner portion (7a1) and an outer portion (7a2), the inner portion of the U-shape cross section (7a1) being in surface contact with the means of ultrasonic vibrations and the outer portion of the U-shape cross section (7a2) being not in surface contact with the means of ultrasonic vibrations.